Skip Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 14, Issue 5

2022 March-1 - 262 articles

Cover Story: In the last decade, many therapeutic options have been approved, improving survival outcomes in advanced prostate cancer (PCa) patients. The emphasis on immune checkpoint inhibitors (ICIs) has led to many trials in this setting, with generally poor results. We discuss the immunobiology of PCa, the current clinical data, and ongoing trials to understand the potential role of ICIs in this disease and the patients’ subset more likely to benefit from them. Current evidence shows the tumor microenvironment (TME) needs a qualitative evaluation, and the prognostic/predictive role of immunotherapy biomarkers needs further assessment in PCa. ICI monotherapy has shown modest efficacy, while combined strategies with other standard therapies have shown some results. ICIs in biomarker-selected patients and new targets modulating the immune TME should be better investigated. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (262)

  • Review
  • Open Access
29 Citations
7,028 Views
22 Pages

The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good

  • Victoria Menéndez,
  • José L. Solórzano,
  • Sara Fernández,
  • Carlos Montalbán and
  • Juan F. García

7 March 2022

The classic Hodgkin lymphoma (cHL) tumor microenvironment (TME) is by far the most abundant component of tumors and is responsible for most of their biological and clinical characteristics. Recent advances in our knowledge of these networks in cellul...

  • Review
  • Open Access
57 Citations
9,847 Views
15 Pages

Neutrophil Extracellular Traps in Cancer Therapy Resistance

  • Muhammad H. Shahzad,
  • Lixuan Feng,
  • Xin Su,
  • Ariane Brassard,
  • Iqraa Dhoparee-Doomah,
  • Lorenzo E. Ferri,
  • Jonathan D. Spicer and
  • Jonathan J. Cools-Lartigue

7 March 2022

Neutrophils and their products are increasingly recognized to have a key influence on cancer progression and response to therapy. Their involvement has been shown in nearly every aspect of cancer pathophysiology with growing evidence now supporting t...

  • Article
  • Open Access
10 Citations
5,417 Views
15 Pages

Anticancer Activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a New Dishevelled 1 Inhibitor

  • Antonio Coluccia,
  • Marianna Bufano,
  • Giuseppe La Regina,
  • Michela Puxeddu,
  • Angelo Toto,
  • Alessio Paone,
  • Amani Bouzidi,
  • Giorgia Musto,
  • Nadia Badolati and
  • Romano Silvestri
  • + 8 authors

7 March 2022

Wingless/integrase-11 (WNT)/β-catenin pathway is a crucial upstream regulator of a huge array of cellular functions. Its dysregulation is correlated to neoplastic cellular transition and cancer proliferation. Members of the Dishevelled (DVL) fam...

  • Article
  • Open Access
32 Citations
4,297 Views
15 Pages

Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer

  • Davide Brocco,
  • Pasquale Simeone,
  • Davide Buca,
  • Pietro Di Marino,
  • Michele De Tursi,
  • Antonino Grassadonia,
  • Laura De Lellis,
  • Maria Teresa Martino,
  • Serena Veschi and
  • Nicola Tinari
  • + 6 authors

7 March 2022

Colorectal cancer (CRC) is one of the most incident and lethal malignancies worldwide. Recent treatment advances prolonged survival in patients with metastatic colorectal cancer (mCRC). However, there are still few biomarkers to guide clinical manage...

  • Article
  • Open Access
14 Citations
4,358 Views
14 Pages

EGFR Mutation-Harboring Lung Cancer Cells Produce CLEC11A with Endothelial Trophic and Tumor-Promoting Activities

  • Tzu-Yin Lin,
  • Chi-Hwa Yang,
  • Hsiao-Chin Chou,
  • Chun-Mei Cheng,
  • Ya-Wen Liu,
  • Jiz-Yuh Wang,
  • Li-Rung Huang,
  • Shih-Feng Tsai,
  • Shiu-Feng Huang and
  • Yi-Rong Chen

7 March 2022

The formation of new blood vessels in solid tumors is regulated by various endothelial trophic factors. We identified that CLEC11A, an extracellular C-type lectin, was over-expressed in lung cancer cell lines harboring mutated EGFR. CLEC11A expressio...

  • Article
  • Open Access
8 Citations
3,710 Views
12 Pages

Prevalence of Cognitive Impairment before Prostate Cancer Treatment

  • Natália Araújo,
  • Adriana Costa,
  • Catarina Lopes,
  • Luisa Lopes-Conceição,
  • Augusto Ferreira,
  • Filipa Carneiro,
  • Jorge Oliveira,
  • Samantha Morais,
  • Luís Pacheco-Figueiredo and
  • Nuno Lunet
  • + 3 authors

7 March 2022

Cognitive impairment is common among patients with different types of cancer, even before cancer treatment, but no data were reported among patients with prostate cancer (PCa), who may be at high risk due to advanced age. This study aims to estimate...

  • Article
  • Open Access
13 Citations
3,830 Views
18 Pages

7 March 2022

Dedifferentiation is the main concern associated with radioactive iodine (RAI) refractoriness in patients with papillary thyroid cancer (PTC), and the underlying mechanisms of PTC dedifferentiation remain unclear. The present work aimed to identify a...

  • Article
  • Open Access
15 Citations
3,818 Views
15 Pages

Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival Benefit

  • Tomohisa Yamamoto,
  • Sohei Satoi,
  • So Yamaki,
  • Daisuke Hashimoto,
  • Mitsuaki Ishida,
  • Tsukasa Ikeura,
  • Satoshi Hirooka,
  • Yuki Matsui,
  • Shogen Boku and
  • Mitsugu Sekimoto
  • + 4 authors

7 March 2022

Background: Intraperitoneal chemotherapy using paclitaxel (i.p.-PTX) is expected to be a new therapeutic strategy for patients with pancreatic ductal adenocarcinoma (PDAC) and peritoneal dissemination. We evaluated the survival benefit of i.p.-PTX co...

  • Article
  • Open Access
7 Citations
3,249 Views
7 Pages

The Clinical Utility and Impact of Next Generation Sequencing in Gynecologic Cancers

  • Vijaya Kadam Maruthi,
  • Mahyar Khazaeli,
  • Devi Jeyachandran and
  • Mohamed Mokhtar Desouki

7 March 2022

Next generation sequencing (NGS) has facilitated the identification of molecularly targeted therapies. However, clinical utility is an emerging challenge. Our objective was to identify the clinical utility of NGS testing in gynecologic cancers. A ret...

  • Article
  • Open Access
7 Citations
6,380 Views
12 Pages

Diagnostic Accuracy of Contrast-Enhanced, Spectral Mammography (CESM) and 3T Magnetic Resonance Compared to Full-Field Digital Mammography plus Ultrasound in Breast Lesions: Results of a (Pilot) Open-Label, Single-Centre Prospective Study

  • Francesca Romana Ferranti,
  • Federica Vasselli,
  • Maddalena Barba,
  • Francesca Sperati,
  • Irene Terrenato,
  • Franco Graziano,
  • Patrizia Vici,
  • Claudio Botti and
  • Antonello Vidiri

7 March 2022

Introduction: To assess the diagnostic accuracy of CESM and 3T MRI compared to full-field digital mammography (FFDM), plus US, in the evaluation of advanced breast lesions. Materials and Methods: Consenting women with suspicious findings underwent FF...

  • Review
  • Open Access
11 Citations
5,414 Views
17 Pages

Oligometastatic Disease in Non-Small-Cell Lung Cancer: An Update

  • Yi-Hsing Chen,
  • Ue-Cheung Ho and
  • Lu-Ting Kuo

6 March 2022

Oligometastatic non-small-cell lung cancer (NSCLC) is a distinct entity that is different from localized and disseminated diseases. The definition of oligometastatic NSCLC varies across studies in past decades owing to the use of different imaging mo...

  • Review
  • Open Access
53 Citations
11,022 Views
19 Pages

Advancements in Oncology with Artificial Intelligence—A Review Article

  • Nikitha Vobugari,
  • Vikranth Raja,
  • Udhav Sethi,
  • Kejal Gandhi,
  • Kishore Raja and
  • Salim R. Surani

6 March 2022

Well-trained machine learning (ML) and artificial intelligence (AI) systems can provide clinicians with therapeutic assistance, potentially increasing efficiency and improving efficacy. ML has demonstrated high accuracy in oncology-related diagnostic...

  • Article
  • Open Access
6 Citations
5,078 Views
11 Pages

Testing for Lynch Syndrome in Endometrial Carcinoma: From Universal to Age-Selective MLH1 Methylation Analysis

  • Annukka Pasanen,
  • Mikko Loukovaara,
  • Elina Kaikkonen,
  • Alisa Olkinuora,
  • Kirsi Pylvänäinen,
  • Pia Alhopuro,
  • Päivi Peltomäki,
  • Jukka-Pekka Mecklin and
  • Ralf Bützow

6 March 2022

International guidelines recommend universal screening of endometrial carcinoma (EC) patients for Lynch syndrome (LS). This screening is generally based on mismatch repair (MMR) protein immunohistochemistry followed by MLH1 methylation analysis of ML...

  • Article
  • Open Access
14 Citations
4,703 Views
16 Pages

A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy

  • Laura Marconato,
  • Alessia Melacarne,
  • Marina Aralla,
  • Silvia Sabattini,
  • Luca Tiraboschi,
  • Valentina Ferrari,
  • Offer Zeira,
  • Andrea Balboni,
  • Eugenio Faroni and
  • Maria Rescigno
  • + 4 authors

6 March 2022

Despite efforts to develop novel treatment strategies, human and canine osteosarcomas continue to have poor prognosis and limited overall survival. The aim of this clinical trial was to test the antitumor effect and safety of multiple dermal administ...

  • Article
  • Open Access
2 Citations
4,362 Views
15 Pages

Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma

  • Jessica Rodrigues Plaça,
  • Arjan Diepstra,
  • Tjitske Los,
  • Matías Mendeville,
  • Annika Seitz,
  • Pieternella J. Lugtenburg,
  • Josée Zijlstra,
  • King Lam,
  • Wilson Araújo da Silva and
  • Marcel Nijland
  • + 3 authors

5 March 2022

Multiple gene expression profiles have been identified in diffuse large B-cell lymphoma (DLBCL). Besides the cell of origin (COO) classifier, no signatures have been reproduced in independent studies or evaluated for capturing distinct aspects of DLB...

  • Review
  • Open Access
15 Citations
5,595 Views
21 Pages

CK1 Is a Druggable Regulator of Microtubule Dynamics and Microtubule-Associated Processes

  • Aileen Roth,
  • Adrian Gihring,
  • Joachim Bischof,
  • Leiling Pan,
  • Franz Oswald and
  • Uwe Knippschild

5 March 2022

Protein kinases of the Casein Kinase 1 family play a vital role in the regulation of numerous cellular processes. Apart from functions associated with regulation of proliferation, differentiation, or apoptosis, localization of several Casein Kinase 1...

  • Article
  • Open Access
4 Citations
3,046 Views
13 Pages

Measuring Walking Speed Failed to Predict Early Death and Toxicity in Elderly Patients with Metastatic Non-Small-Cell Lung Cancer (NSCLC) Selected for Undergoing First-Line Systemic Treatment: An Observational Exploratory Study

  • Amélie Aregui,
  • Johan Pluvy,
  • Manuel Sanchez,
  • Theresa Israel,
  • Hélène Esnault,
  • Alice Guyard,
  • Marie Meyer,
  • Antoine Khalil,
  • Gérard Zalcman and
  • Valérie Gounant
  • + 1 author

5 March 2022

Walking speed (WS) has emerged as a potential predictor of mortality in elderly cancer patients, yet data involving non-small-cell lung cancer (NSCLC) patients are scarce. Our prospective exploratory study sought to determine whether WS would predict...

  • Article
  • Open Access
23 Citations
8,598 Views
30 Pages

5 March 2022

Metformin and 2-deoxy-D-glucose (2DG) exhibit multiple metabolic and immunomodulatory anti-cancer effects, such as suppressed proliferation or PD-L1 expression. Their combination or 2DG alone induce triple-negative breast cancer (TNBC) cell detachmen...

  • Review
  • Open Access
15 Citations
5,031 Views
21 Pages

Hemodynamic Imaging in Cerebral Diffuse Glioma—Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions

  • Vittorio Stumpo,
  • Lelio Guida,
  • Jacopo Bellomo,
  • Christiaan Hendrik Bas Van Niftrik,
  • Martina Sebök,
  • Moncef Berhouma,
  • Andrea Bink,
  • Michael Weller,
  • Zsolt Kulcsar and
  • Jorn Fierstra
  • + 1 author

5 March 2022

Gliomas, and glioblastoma in particular, exhibit an extensive intra- and inter-tumoral molecular heterogeneity which represents complex biological features correlating to the efficacy of treatment response and survival. From a neuroimaging point of v...

  • Article
  • Open Access
3 Citations
3,478 Views
21 Pages

A Novel and Automated Approach to Classify Radiation Induced Lung Tissue Damage on CT Scans

  • Adam Szmul,
  • Edward Chandy,
  • Catarina Veiga,
  • Joseph Jacob,
  • Alkisti Stavropoulou,
  • David Landau,
  • Crispin T. Hiley and
  • Jamie R. McClelland

5 March 2022

Radiation-induced lung damage (RILD) is a common side effect of radiotherapy (RT). The ability to automatically segment, classify, and quantify different types of lung parenchymal change is essential to uncover underlying patterns of RILD and their e...

  • Review
  • Open Access
12 Citations
6,020 Views
26 Pages

Persistent Large Granular Lymphocyte Clonal Expansions: “The Root of Many Evils”—And of Some Goodness

  • Carlos Bravo-Pérez,
  • Salvador Carrillo-Tornel,
  • Esmeralda García-Torralba and
  • Andrés Jerez

5 March 2022

Large granular lymphocyte leukemia (LGLL) is a chronic disease of either mature phenotype cytotoxic CD3+ T lymphocytes or CD3- NK cells. LGLL diagnosis is hampered by the fact that reactive persistent clonal LGL expansions may fulfill the current cri...

  • Article
  • Open Access
11 Citations
4,644 Views
13 Pages

Fluorescence Polarization Imaging of Methylene Blue Facilitates Quantitative Detection of Thyroid Cancer in Single Cells

  • Peter R. Jermain,
  • Andrew H. Fischer,
  • Lija Joseph,
  • Alona Muzikansky and
  • Anna N. Yaroslavsky

5 March 2022

Background: Diagnostic accuracy of the standard of care fine-needle aspiration cytology (FNAC) remains a significant problem in thyroid oncology. Therefore, a robust and accurate method for reducing uncertainty of cytopathological evaluation would be...

  • Perspective
  • Open Access
4 Citations
4,169 Views
12 Pages

4 March 2022

A stem-cell theory of cancer predicates that not only does the cell affect the niche, the niche also affects the cell. It implicates that even though genetic makeup may be supreme, cellular context is key. When we attempt to solve the mystery of a lo...

  • Article
  • Open Access
1 Citations
3,406 Views
13 Pages

Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker

  • Raphael Naccache,
  • Younes Belkouchi,
  • Littisha Lawrance,
  • Baya Benatsou,
  • Joya Hadchiti,
  • Paul-Henry Cournede,
  • Samy Ammari,
  • Hugues Talbot and
  • Nathalie Lassau

4 March 2022

Purpose: The objective of our study is to propose fast, cost-effective, convenient, and effective biomarkers using the perfusion parameters from dynamic contrast-enhanced ultrasound (DCE-US) for the evaluation of immune checkpoint inhibitors (ICI) ea...

  • Systematic Review
  • Open Access
36 Citations
7,219 Views
18 Pages

Metformin Intervention—A Panacea for Cancer Treatment?

  • Angelika Buczyńska,
  • Iwona Sidorkiewicz,
  • Adam Jacek Krętowski,
  • Monika Zbucka-Krętowska and
  • Agnieszka Adamska

4 March 2022

The molecular mechanism of action and the individual influence of various metabolic pathways related to metformin intervention are under current investigation. The available data suggest that metformin provides many advantages, exhibiting anti-inflam...

  • Review
  • Open Access
16 Citations
6,224 Views
20 Pages

Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia

  • Claudia Fiñana,
  • Noel Gómez-Molina,
  • Sandra Alonso-Moreno and
  • Laura Belver

4 March 2022

Juvenile myelomonocytic leukemia (JMML) is a rare myelodysplastic/myeloproliferative neoplasm of early childhood. Most of JMML patients experience an aggressive clinical course of the disease and require hematopoietic stem cell transplantation, which...

  • Review
  • Open Access
6 Citations
3,159 Views
16 Pages

Safety and Feasibility of Lung Cancer Surgery under the COVID-19 Circumstance

  • Lawek Berzenji,
  • Leonie Vercauteren,
  • Suresh K. Yogeswaran,
  • Patrick Lauwers,
  • Jeroen M. H. Hendriks and
  • Paul E. Van Schil

4 March 2022

The current coronavirus disease 2019 (COVID-19) pandemic has forced healthcare providers worldwide to adapt their practices. Our understanding of the effects of COVID-19 has increased exponentially since the beginning of the pandemic. Data from large...

  • Article
  • Open Access
4 Citations
3,792 Views
16 Pages

4 March 2022

Serum immunoglobulin G (IgG) glycosylation, especially galactosylation, has been found to be related to a variety of tumors, including hepatocellular carcinoma (HCC). However, whether IgG glycan changes occur in the early stages of HCC formation rema...

  • Article
  • Open Access
12 Citations
8,160 Views
13 Pages

Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer Tumors

  • Jouni Kujala,
  • Jaana M. Hartikainen,
  • Maria Tengström,
  • Reijo Sironen,
  • Päivi Auvinen,
  • Veli-Matti Kosma and
  • Arto Mannermaa

4 March 2022

Liquid biopsy of cell-free DNA (cfDNA) is proposed as a potential method for the early detection of breast cancer (BC) metastases and following the clonal evolution of BC. Though the use of liquid biopsy is a widely discussed topic in the field, only...

  • Article
  • Open Access
6 Citations
3,694 Views
16 Pages

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy

  • Sylvie Giacchetti,
  • Lilith Faucheux,
  • Charlotte Gardair,
  • Caroline Cuvier,
  • Anne de Roquancourt,
  • Luca Campedel,
  • David Groheux,
  • Cedric de Bazelaire,
  • Jacqueline Lehmann-Che and
  • Anne-Sophie Hamy
  • + 12 authors

4 March 2022

Background: Patients with triple-negative breast cancers (TNBC) have a poor prognosis unless a pathological complete response (pCR) is achieved after neoadjuvant chemotherapy (NAC). Few studies have analyzed changes in TIL levels following dose-dense...

  • Article
  • Open Access
2 Citations
4,155 Views
20 Pages

Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center

  • Henry Hiep Vo,
  • Carrie Cartwright,
  • I-Wen Song,
  • Daniel D. Karp,
  • Graciela M. Nogueras Gonzalez,
  • Yuran Xie,
  • Michael Karol,
  • Matthew Hitron,
  • David Vining and
  • Apostolia-Maria Tsimberidou

4 March 2022

Background: BBI608 is an investigational reactive oxygen species generator that affects several molecular pathways. We investigated BBI608 combined with immune checkpoint inhibitors in patients with advanced cancers. Methods: BBI608 (orally twice dai...

  • Article
  • Open Access
12 Citations
5,301 Views
13 Pages

Impact of Three-Month Androgen Deprivation Therapy on [68Ga]Ga-PSMA-11 PET/CT Indices in Men with Advanced Prostate Cancer—Results from a Pilot Prospective Study

  • Jing-Ren Tseng,
  • Szu-Han Chang,
  • Yao-Yu Wu,
  • Kang-Hsing Fan,
  • Kai-Jie Yu,
  • Lan-Yan Yang,
  • Ing-Tsung Hsiao,
  • Feng-Yuan Liu and
  • See-Tong Pang

4 March 2022

Purpose: The purpose of this pilot prospective study is to examine the gallium-68-prostate-specific membrane antigen-11 ([68Ga]Ga-PSMA-11) positron emission tomography/computed tomography (PET/CT) imaging response in patients with advanced or metasta...

  • Article
  • Open Access
6 Citations
4,455 Views
16 Pages

Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer

  • Torgeir Mo,
  • Siri Helene Bertelsen Brandal,
  • Alvaro Köhn-Luque,
  • Olav Engebraaten,
  • Vessela N. Kristensen,
  • Thomas Fleischer,
  • Tord Hompland and
  • Therese Seierstad

4 March 2022

The purpose of the present study is to investigate if consumption and supply hypoxia (CSH) MR-imaging can depict breast cancer hypoxia, using the CSH-method initially developed for prostate cancer. Furthermore, to develop a generalized pan-cancer app...

  • Article
  • Open Access
4 Citations
4,024 Views
13 Pages

Management and Outcome of Young Women (≤40 Years) with Breast Cancer in Switzerland

  • Giacomo Montagna,
  • Robin Schaffar,
  • Andrea Bordoni,
  • Alessandra Spitale,
  • Daniela A. Terribile,
  • Lorenzo Rossi,
  • Yvan Bergeron,
  • Bernadette W. A. van der Linden,
  • Isabelle Konzelmann and
  • Elisabetta Rapiti
  • + 6 authors

4 March 2022

Background: An increase in breast cancer (BC) incidence in young women (YW) as well as disparities in BC outcomes have been reported in Switzerland. We sought to evaluate treatment and outcome differences among YW with BC (YWBC). Methods: YW diagnose...

  • Article
  • Open Access
24 Citations
5,231 Views
18 Pages

Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy

  • Mitchell S. von Itzstein,
  • Amrit S. Gonugunta,
  • Thomas Sheffield,
  • Jade Homsi,
  • Jonathan E. Dowell,
  • Andrew Y. Koh,
  • Prithvi Raj,
  • Farjana Fattah,
  • Yiqing Wang and
  • David E. Gerber
  • + 11 authors

4 March 2022

Antibiotic administration is associated with worse clinical outcomes and changes to the gut microbiome in cancer patients receiving immune checkpoint inhibitors (ICI). However, the effects of antibiotics on systemic immune function are unknown. We, t...

  • Review
  • Open Access
26 Citations
8,937 Views
24 Pages

High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand

  • Nicola Zambrano,
  • Guendalina Froechlich,
  • Dejan Lazarevic,
  • Margherita Passariello,
  • Alfredo Nicosia,
  • Claudia De Lorenzo,
  • Marco J. Morelli and
  • Emanuele Sasso

4 March 2022

Monoclonal antibodies are among the most powerful therapeutics in modern medicine. Since the approval of the first therapeutic antibody in 1986, monoclonal antibodies keep holding great expectations for application in a range of clinical indications,...

  • Review
  • Open Access
13 Citations
4,348 Views
11 Pages

4 March 2022

Since the 1970s, a connection between the skin’s microbiota and cutaneous T-cell lymphomas (CTCL) was suggested. New techniques such as next-generation sequencing technologies enable the examination of the nuanced interplay between microbes and...

  • Article
  • Open Access
13 Citations
3,940 Views
14 Pages

Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer

  • Nour Abuhadra,
  • Ryan Sun,
  • Jennifer K. Litton,
  • Gaiane M. Rauch,
  • Clinton Yam,
  • Jeffrey T. Chang,
  • Sahil Seth,
  • Roland Bassett,
  • Bora Lim and
  • Lei Huo
  • + 19 authors

4 March 2022

High stromal tumor-infiltrating lymphocytes (sTILs) are associated with an improved pathologic complete response (pCR) and survival in triple-negative breast cancer (TNBC). We hypothesized that high baseline sTILs would have a favorable prognostic im...

  • Article
  • Open Access
5 Citations
5,517 Views
20 Pages

Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities

  • Anjan Motamarry,
  • A. Marissa Wolfe,
  • Krishna K. Ramajayam,
  • Sanket Pattanaik,
  • Thomas Benton,
  • Yuri Peterson,
  • Pegah Faridi,
  • Punit Prakash,
  • Katherine Twombley and
  • Dieter Haemmerich

4 March 2022

Thermosensitive liposomal doxorubicin (TSL-Dox) combined with localized hyperthermia enables targeted drug delivery. Tumor drug uptake occurs only during hyperthermia. We developed a novel method for removal of systemic TSL-Dox remaining after hypert...

  • Article
  • Open Access
7 Citations
3,006 Views
11 Pages

Impact of Dose Escalation on the Efficacy of Salvage Radiotherapy for Recurrent Prostate Cancer—A Risk-Adjusted, Matched-Pair Analysis

  • Dirk Böhmer,
  • Alessandra Siegmann,
  • Sophia Scharl,
  • Christian Ruf,
  • Thomas Wiegel,
  • Manuel Krafcsik and
  • Reinhard Thamm

4 March 2022

Previous randomized trials have not provided conclusive evidence about dose escalations and associated toxicities for salvage radiotherapy (SRT) in prostate cancer. Here, we retrospectively analyzed whether dose escalations influenced progression-fre...

  • Review
  • Open Access
70 Citations
13,376 Views
19 Pages

Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance

  • Damien Reita,
  • Lucile Pabst,
  • Erwan Pencreach,
  • Eric Guérin,
  • Laurent Dano,
  • Valérie Rimelen,
  • Anne-Claire Voegeli,
  • Laurent Vallat,
  • Céline Mascaux and
  • Michèle Beau-Faller

4 March 2022

KRAS is the most frequently mutated oncogene in non-small cell lung cancers (NSCLC), with a frequency of around 30%, and encoding a GTPAse that cycles between active form (GTP-bound) to inactive form (GDP-bound). The KRAS mutations favor the active f...

  • Article
  • Open Access
14 Citations
3,590 Views
19 Pages

Cancer Cells Promote Phenotypic Alterations in Hepatocytes at the Edge of Cancer Cell Nests to Facilitate Vessel Co-Option Establishment in Colorectal Cancer Liver Metastases

  • Miran Rada,
  • Migmar Tsamchoe,
  • Audrey Kapelanski-Lamoureux,
  • Nour Hassan,
  • Jessica Bloom,
  • Stephanie Petrillo,
  • Diane H. Kim,
  • Anthoula Lazaris and
  • Peter Metrakos

4 March 2022

Vessel co-option is correlated with resistance against anti-angiogenic therapy in colorectal cancer liver metastases (CRCLM). Vessel co-opting lesions are characterized by highly motile cancer cells that move toward and along the pre-existing vessels...

  • Review
  • Open Access
72 Citations
7,290 Views
25 Pages

Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities

  • Johannes K. Andersen,
  • Hrvoje Miletic and
  • Jubayer A. Hossain

4 March 2022

Glioma refers to a group of primary brain tumors which includes glioblastoma (GBM), astrocytoma and oligodendroglioma as major entities. Among these, GBM is the most frequent and most malignant one. The highly infiltrative nature of gliomas, and thei...

  • Article
  • Open Access
12 Citations
3,212 Views
13 Pages

Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients

  • Marie Beck Enemark,
  • Trine Engelbrecht Hybel,
  • Charlotte Madsen,
  • Kristina Lystlund Lauridsen,
  • Bent Honoré,
  • Trine Lindhardt Plesner,
  • Stephen Hamilton-Dutoit,
  • Francesco d’Amore and
  • Maja Ludvigsen

4 March 2022

Histological transformation (HT) remains the leading cause of mortality in follicular lymphoma (FL), underlining the need to identify reliable transformation predictors. The hyaluronic acid receptors CD44 and the receptor for hyaluronan mediated moti...

  • Article
  • Open Access
11 Citations
4,167 Views
21 Pages

Role of Neural (N)-Cadherin in Breast Cancer Cell Stemness and Dormancy in the Bone Microenvironment

  • Antonio Maurizi,
  • Michela Ciocca,
  • Cristiano Giuliani,
  • Ilaria Di Carlo and
  • Anna Teti

4 March 2022

Breast cancer cells that interact with spindle-shaped N-Cadherin+ Osteoblasts (SNOs) are recognised to become dormant through a Notch2-dependent mechanism. We found that Notch2High human BrCa MDA-MB231 (MDA) cells also expressed high level of N-Cadhe...

  • Article
  • Open Access
16 Citations
6,211 Views
21 Pages

4 March 2022

Glioblastoma stem-like cells (GSCs) drive tumor initiation, cancer invasion, immune evasion, and therapeutic resistance and are thus a key therapeutic target for improving treatment for glioblastoma multiforme (GBM). We previously identified calcium/...

  • Article
  • Open Access
10 Citations
5,222 Views
12 Pages

Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV

  • Jean-Pierre Gerard,
  • Arthur Sun Myint,
  • Nicolas Barbet,
  • Catherine Dejean,
  • Brice Thamphya,
  • Jocelyn Gal,
  • Lucile Montagne and
  • Te Vuong

3 March 2022

Rectal adenocarcinoma is a quite radioresistant tumor. In order to achieve non-operative management (NOM) radiotherapy plays a major role. Targeted radiotherapy aiming at high precision 3D radiotherapy uses stereotactic image-guided external beam rad...

  • Article
  • Open Access
35 Citations
4,241 Views
14 Pages

Thermal Ablation of Liver Tumors Guided by Augmented Reality: An Initial Clinical Experience

  • Marco Solbiati,
  • Tiziana Ierace,
  • Riccardo Muglia,
  • Vittorio Pedicini,
  • Roberto Iezzi,
  • Katia M. Passera,
  • Alessandro C. Rotilio,
  • S. Nahum Goldberg and
  • Luigi A. Solbiati

3 March 2022

Background: Over the last two decades, augmented reality (AR) has been used as a visualization tool in many medical fields in order to increase precision, limit the radiation dose, and decrease the variability among operators. Here, we report the fir...

  • Article
  • Open Access
17 Citations
5,820 Views
25 Pages

Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways

  • Khoa Pham,
  • Allison R. Hanaford,
  • Brad A. Poore,
  • Micah J. Maxwell,
  • Heather Sweeney,
  • Akhila Parthasarathy,
  • Jesse Alt,
  • Rana Rais,
  • Barbara S. Slusher and
  • Eric H. Raabe
  • + 1 author

3 March 2022

Reprograming of cellular metabolism is a hallmark of cancer. Altering metabolism allows cancer cells to overcome unfavorable microenvironment conditions and to proliferate and invade. Medulloblastoma is the most common malignant brain tumor of childr...

of 6

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694